{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:55:50Z","timestamp":1791078950392,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.ijpharm.2006.07.006","type":"journal-article","created":{"date-parts":[[2006,7,11]],"date-time":"2006-07-11T14:02:05Z","timestamp":1152626525000},"page":"37-42","source":"Crossref","is-referenced-by-count":58,"title":["Encapsulation of antiviral nucleotide analogues azidothymidine-triphosphate and cidofovir in poly(iso-butylcyanoacrylate) nanocapsules"],"prefix":"10.1016","volume":"324","author":[{"given":"H.","family":"Hillaireau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Le Doan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Besnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Chacun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Janin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Couvreur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2006.07.006_bib1","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1016\/S0021-9258(18)83322-1","article-title":"Differential patterns of intracellular metabolism of 2\u2032,3\u2032-didehydro-2\u2032,3\u2032-dideoxythymidine and 3\u2032-azido-2\u2032,3\u2032-dideoxythymidine, two potent anti-human immunodeficiency virus compounds","volume":"264","author":"Balzarini","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2006.07.006_bib2","first-page":"19","article-title":"Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus)","volume":"58","author":"De Clercq","year":"1996","journal-title":"Verh. K. Acad. Geneesk. Belg."},{"key":"10.1016\/j.ijpharm.2006.07.006_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(02)00008-6","article-title":"Cidofovir in the treatment of poxvirus infections","volume":"55","author":"De Clercq","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ijpharm.2006.07.006_bib4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1023\/A:1015819706491","article-title":"Vidarabine-loaded nanoparticles: a physicochemical study","volume":"7","author":"Guise","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.07.006_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/1381612003400687","article-title":"Design of anti-HIV compounds: from nucleoside to nucleoside 5\u2032-triphosphate analogs. Problems and perspectives","volume":"6","author":"Kukhanova","year":"2000","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijpharm.2006.07.006_bib6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1006\/bbrc.2000.3963","article-title":"EWS fli-1 antisense nanocapsules inhibits ewing sarcoma-related tumor in mice","volume":"279","author":"Lambert","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpharm.2006.07.006_bib7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1023\/A:1007582332491","article-title":"Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides","volume":"17","author":"Lambert","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.07.006_bib8","series-title":"Reverse Transcriptase","first-page":"205","article-title":"Inhibitors of HIV reverse transcriptase as antiviral agents and drug resistance","author":"Larder","year":"1993"},{"key":"10.1016\/j.ijpharm.2006.07.006_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0168-3659(97)00105-3","article-title":"Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats","volume":"50","author":"Lobenberg","year":"1998","journal-title":"J. Contr. Rel."},{"key":"10.1016\/j.ijpharm.2006.07.006_bib10","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1089\/aid.1996.12.1709","article-title":"Macrophage targeting of azidothymidine: a promising strategy for AIDS therapy","volume":"12","author":"Lobenberg","year":"1996","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.ijpharm.2006.07.006_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0378-4347(92)80368-Z","article-title":"Simultaneous analysis of azidothymidine and its mono-, di- and triphosphate derivatives in biological fluids, tissue and cultured cells by a rapid high-performance liquid chromatographic method","volume":"579","author":"Molema","year":"1992","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.ijpharm.2006.07.006_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0939-6411(01)00245-4","article-title":"Factors influencing the entrapment of hydrophilic compounds in nanocapsules prepared by interfacial polymerisation of water-in-oil microemulsions","volume":"53","author":"Pitaksuteepong","year":"2002","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2006.07.006_bib13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1023\/A:1015852732512","article-title":"Phagocytosis of nanoparticles by human immunodeficiency virus (HIV)-infected macrophages: a possibility for antiviral drug targeting","volume":"9","author":"Schafer","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.07.006_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0378-5173(03)00373-9","article-title":"Poly(butylcyanoacrylate) nanoparticles for topical delivery of 5-fluorouracil","volume":"263","author":"Simeonova","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2006.07.006_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/1061186042000207011","article-title":"Study on the role of 5-fluorouracil in the polymerization of butylcyanoacrylate during the formation of nanoparticles","volume":"12","author":"Simeonova","year":"2004","journal-title":"J. Drug Target"},{"key":"10.1016\/j.ijpharm.2006.07.006_bib16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0006-2952(94)00453-S","article-title":"Cytotoxicity of 3\u2032-azido-3\u2032-deoxythymidine correlates with 3\u2032-azidothymidine-5\u2032-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3\u2032-azidothymidine-5\u2032-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells","volume":"49","author":"Tornevik","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpharm.2006.07.006_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2003.07.001","article-title":"Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases","volume":"100","author":"Van Rompay","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2006.07.006_bib18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1211\/0022357021778736","article-title":"In vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion","volume":"54","author":"Watnasirichaikul","year":"2002","journal-title":"J. Pharm. Pharmacol."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517306005588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517306005588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T14:14:20Z","timestamp":1627568060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517306005588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0378517306005588"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2006.07.006","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}